EyeMove Private

EyeMove is a program to reveal the initial stages of Parkinson's disease based on eye movemets. Early diagnosis of degenerative diseases of the central nervous system. If adequate methods of early diagnosis appear, this will allow the patient to continue his normal existence and his independence from others for a much longer period than even now using the existing methods of treatment.

Technology: Genetic Test & Molecular Diagnostics
Headquarters: Moscow, Moscow City, Russian Federation
Funding Status: Seed
Founded Date: 01.01.2016
Last Funding Type: Seed
Investors Number: 2
Industry: PharmTech
Investor Type: For Profit